Stock Research: Merck (USA)

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Merck (USA)

NYSE:MRK US58933Y1055
57
  • Value
    77
  • Growth
    41
  • Safety
    Safety
    58
  • Combined
    70
  • Sentiment
    42
  • 360° View
    360° View
    57
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Merck & Co., Inc. is a global healthcare company providing health solutions through prescription medicines, vaccines, and animal health products. It operates in the pharmaceutical and animal health industries. The company sells its products globally. In the last fiscal year, the company had a market cap of $204699 million, profits of $49470 million, revenue of $64168 million, and 75000 employees.

more
Index
Dow Jones
Dividends USA
Diversity USA
D.J. US Pharmaceutical
S&P 500
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 8-Jan-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
77 84 60 81
Growth
41 39 43 59
Safety
Safety
58 42 46 94
Sentiment
42 34 88 96
360° View
360° View
57 28 73 100
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
30 39 57 27
Opinions Change
53 15 50 83
Pro Holdings
n/a 86 96 96
Market Pulse
29 37 74 72
Sentiment
42 34 88 96
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
77 84 60 81
Growth
41 39 43 59
Safety Safety
58 42 46 94
Combined
70 47 44 98
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
35 32 24 36
Price vs. Earnings (P/E)
68 77 65 88
Price vs. Book (P/B)
24 32 10 12
Dividend Yield
98 96 89 94
Value
77 84 60 81
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
46 49 56 51
Profit Growth
46 56 10 62
Capital Growth
28 40 56 32
Stock Returns
53 27 59 73
Growth
41 39 43 59
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
42 31 45 34
Refinancing
24 10 23 95
Liquidity
89 94 82 89
Safety Safety
58 42 46 94

Similar Stocks

Discover high‑ranked alternatives to Merck (USA) and broaden your portfolio horizons.

Intuit

NasdaqGS:INTU
Country: USA
Industry: Application Software
Size: X-Large
Full Stock Analysis

Alphabet

NasdaqGS:GOOG.L
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Cigna

NYSE:CI
Country: USA
Industry: Health Care Services
Size: XX-Large
Full Stock Analysis

Cognizant Technology

NasdaqGS:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

This stock is a good value with safe financing, but has low growth and negative sentiment. It is a good option for a cautious value investor looking for stability but who can tolerate low momentum and skeptical professional opinion.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: